Granulomatosis with polyangiitis (Wegener's)
Other Names for this Disease
- Midline granulomatosis
- Wegener granulomatosis
Your QuestionMy husband has been diagnosed with Wegener's granulomatosis. How might this condition be treated? How can I learn about research involving this condition?
We have identified the following information that we hope you find helpful. If you still have questions, please contact us.
Questions on this page
- Bisphosphonate (Fosamax) to prevent bone loss caused by prednisone
- Folic acid or folinic acid (leucovorin) -- if you are taking methotrexate
- Trimethoprim/sulfamethoxazole to prevent lung infections
National Institute of Allergy and Infectious Diseases (NIAID).
Medscape Reference also provides information about the treatment of Wegener's granulomatosis, including a section detailing alternative and/or promising therapies.
Research scientists at the National Institutes of Allergy and Infectious Diseases (NIAID) have been studying Wegener's granulomatosis since the 1970s. While strides have been made towards treating this condition, the side effects experienced by many patients remains a concern. That is why researchers continue to study this disease, in the hopes of better understanding its causes and to develop new and better treatments.
NIAID and other parts of the National Institutes of Health (NIH) support research on Wegener's granulomatosis and related forms of vasculitis at medical centers throughout the United States through the extramural grants program. NIH supports the Vasculitis Clinical Research Consortium (VCRC), for example. The multicenter VCRC fosters and facilitates clinical investigation in the inflammatory vasculitides, including Wegener's granulomatosis.
More information about VCRC is available at: http://rarediseasesnetwork.epi.usf.edu/vcrc/. Much of the information available at this site is designed to help people manage their disease.
The U.S. National Institutes of Health, through the National Library of Medicine, developed ClinicalTrials.gov to provide patients, family members, and members of the public with current information on clinical research studies. ClinicalTrials.gov lists trials that are studying or have studied Wegener's granulomatosis. Click on the link to go to ClinicalTrials.gov to read descriptions of these studies. After you click on a study, review its "eligibility" criteria to determine its appropriateness. Use the study’s contact information to learn more. Check this site often for regular updates.
You can also contact the Patient Recruitment and Public Liaison (PRPL) Office at the National Institutes of Health (NIH). We recommend calling the toll-free number listed below to speak with a specialist, who can help you determine if you are eligible for any clinical trials. If you are located outside the United States, and would like to be contacted via telephone, you will need to provide your telephone number in full, including area code and international dialing prefix.
Patient Recruitment and Public Liaison Office
NIH Clinical Center
Bethesda, Maryland 20892-2655
Web site: http://clinicalcenter.nih.gov/
If you are interested in enrolling in a clinical trial, you can find helpful general information on clinical trials at the following ClinicalTrials.gov Web page.
- Granulomatosis with Polyangiitis (Wegener's). MedlinePlus. March 25, 2014; http://www.nlm.nih.gov/medlineplus/wegenersgranulomatosis.html. Accessed 4/29/2014.
- Wegener's Granulomatosis. NIAID. April 26, 2011; http://www.niaid.nih.gov/topics/wegeners/Pages/Default.aspx. Accessed 7/27/2011.
- Granulomatosis with polyangiitis (Wegener's) (GPA). Vasculitis Clinical Research Consortium. http://rarediseasesnetwork.epi.usf.edu/vcrc/learnmore/definitions.htm#wg. Accessed 4/29/2014.
- Wegener's Granulomatosis. National Institute of Allergy and Infectious Diseases (NIAID). http://www.niaid.nih.gov/topics/gpa/Documents/wegeners.pdf. Accessed 4/29/2014.